Verizon has the largest post-paid subscriber base in the U.S., but can it keep growing its digital business and fend off hungry rivals?
It's unclear how much of the hefty $4,500 price pharmacy benefit managers or insurers will agree to pay to keep Auvi-Q free for most patients.
The meeting comes as part of a broader push by the new president to revitalize the U.S. manufacturing footprint and add jobs.
Taking a historical perspective can help you handle it.
Tech owes a lot to its arrogant past, Recode executive editor Kara Swisher said.
The company could soon see some tire kickers.
If President Donald Trump is worried about violating the Constitution with his business interests, he's not showing it.
Performance of liquid alternatives in 2016 was mediocre, with most indices up by low- to mid-single digits. That does not mean investors should give up on the asset class.
There are several reasons why Celgene should buy Biogen.
The car rental company said they were worried about "creeping control" in a move that comes as an agreement between the company and SRS Investment Management is set to expire.
Investors will focus on the company's full-year guidance.
The combination of the insurance giants was found to be a threat to competition.
Investors who want to hedge against a market pullback may way to buy the precious metal.
Check out Jim and TheStreet editorial team’s latest analysis and commentary on what’s moving markets now.